S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Closed â€ĸ 05:21 AM ET

CNTN

Canton Strategic Holdings, Inc.

Price Chart
Latest Quote

$3.35

-0.19 (-5.37%)
Current Price
Previous Close $3.54
Open $3.48
Day High $3.50
Day Low $3.18
Volume 2,762,822
Fetched: 2026-06-20T08:42:09
Stock Information
Shares Outstanding 69.80M
Cash Equivalents $41.53M
Net Income $-80.72M
Sector Healthcare
Industry Biotechnology
Market Cap $233.85M
EPS (TTM) $-0.36
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$188.82M
Income$-80.72M
Book/sh$8.29
Cash/sh$0.59
Employees12
Financial Ratios
Quick Ratio36.39
Current Ratio37.75
Returns & Margins
ROA-11.60%
ROE-34.42%
Ownership
Insider Ownership19.20%
Institutional Ownership18.29%
Insider & Institutional transactions data not available
Valuation Ratios
P/B0.40
Analyst Data
Recommendationnone
Technical Indicators
SMA20$2.99
SMA50$3.19
SMA200$3.31
RSI55.23
ATR0.3911
Shares Float62.84M
Short Float4.66%
Short Ratio6.07
Volatility1.43
Rel Volume2.52
Performance History
Week+10.93%
Month+2.60%
Quarter-0.89%
6 Months+39.00%
YTD-0.89%
Year+132.64%
3 Years-97.74%
10 Years-99.74%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $3.35 2,767,000
2026-06-17 $3.54 1,385,900
2026-06-16 $3.30 2,286,400
2026-06-15 $3.21 1,007,500
2026-06-12 $3.09 777,300
2026-06-11 $3.02 1,171,100
2026-06-10 $2.95 1,024,700
2026-06-09 $2.68 994,100
2026-06-08 $2.65 988,200
2026-06-05 $2.30 920,000
2026-06-04 $2.45 669,900
2026-06-03 $2.45 657,100
2026-06-02 $2.37 2,615,300
2026-06-01 $2.81 1,491,600
2026-05-29 $3.10 754,100
2026-05-28 $3.11 631,400
2026-05-27 $3.23 551,100
2026-05-26 $3.29 382,100
2026-05-22 $3.52 610,800
2026-05-21 $3.35 264,000
2026-05-20 $3.25 260,000
2026-05-19 $3.27 357,100
About Canton Strategic Holdings, Inc.

Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management. It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $0 $0 $0 $0
Operating Revenue $0 $0 $0 $0
Expenses
Interest Expense $28,345 $13,684 $16,505 $1,591,244
Total Expenses $20,106,066 $12,433,792 $9,455,220 $6,881,938
Other Income Expense $-22,010,362 - - -
Other Non Operating Income Expenses $-22,010,362 - - -
Net Non Operating Interest Income Expense $13,065 $236,224 $136,126 $-1,591,244
Interest Expense Non Operating $28,345 $13,684 $16,505 $1,591,244
Operating Expense $20,106,066 $12,433,792 $9,455,220 $6,881,938
General And Administrative Expense $17,032,102 $6,041,695 $5,895,585 $4,603,514
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-35,916,250 $-12,197,568 $-9,319,094 $-8,473,182
Net Interest Income $13,065 $236,224 $136,126 $-1,591,244
Interest Income $41,410 $249,908 $152,631 $0
Normalized Income $-35,916,250 $-12,197,568 $-9,319,094 $-8,473,182
Net Income From Continuing And Discontinued Operation $-35,916,250 $-12,197,568 $-9,319,094 $-8,473,182
Total Operating Income As Reported $-20,106,066 $-12,433,792 $-9,455,220 $-6,881,938
Net Income Common Stockholders $-35,916,250 $-12,197,568 $-9,319,094 $-8,473,182
Net Income $-35,916,250 $-12,197,568 $-9,319,094 $-8,473,182
Net Income Including Noncontrolling Interests $-35,916,250 $-12,197,568 $-9,319,094 $-8,473,182
Net Income Continuous Operations $-35,916,250 $-12,197,568 $-9,319,094 $-8,473,182
Pretax Income $-42,103,363 $-12,197,568 $-9,319,094 $-8,473,182
Interest Income Non Operating $41,410 $249,908 $152,631 $0
Operating Income $-20,106,066 $-12,433,792 $-9,455,220 $-6,881,938
Special Income Charges - - - -
Per Share
Diluted EPS $-1.12 $-9.41 $-107.02 $-280.80
Basic EPS $-1.12 $-9.41 $-107.02 $-280.80
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-42,075,018 $-12,183,884 $-9,302,589 $-6,881,938
EBITDA (Bullshit earnings) $-42,075,018 $-12,183,884 $-9,302,589 $-6,881,938
EBIT $-42,075,018 $-12,183,884 $-9,302,589 $-6,881,938
Diluted Average Shares $32,049,310 $1,296,290 $87,079 $30,179
Basic Average Shares $32,049,310 $1,296,290 $87,079 $30,179
Diluted NI Availto Com Stockholders $-35,916,250 $-12,197,568 $-9,319,094 $-8,473,182
Tax Provision $-6,187,113 $0 - -
Research And Development $3,073,964 $6,392,097 $3,559,635 $2,278,424
Selling General And Administration $17,032,102 $6,041,695 $5,895,585 $4,603,514
Other Gand A $17,032,102 $6,041,695 $5,895,585 $4,603,514
Total Unusual Items - - - -
Total Unusual Items Excluding Goodwill - - - -
Restructuring And Mergern Acquisition - - - -
Fetched: 2026-06-14
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-103,834,489 $1,307,642 $9,131,347 $5,543,655
Total Assets $519,146,435 $3,721,624 $10,946,393 $6,688,628
Total Non Current Assets $501,760,369 $0 $0 $0
Goodwill And Other Intangible Assets $501,760,369 $0 - -
Other Intangible Assets $501,760,369 - - -
Current Assets $17,386,066 $3,721,624 $10,946,393 $6,688,628
Other Current Assets $353,318 $45,263 $11,041 $178,094
Current Deferred Assets $0 $117,000 $0 $0
Cash Cash Equivalents And Short Term Investments $17,032,748 $3,559,361 $10,935,352 $6,510,534
Cash And Cash Equivalents $17,032,748 $3,559,361 $10,935,352 $6,510,534
Cash Financial $17,032,748 $3,559,361 $10,935,352 $6,510,534
Prepaid Assets - - - -
Debt
Net Debt - - - -
Total Debt - - - -
Long Term Debt And Capital Lease Obligation - - - -
Long Term Debt - - - -
Current Debt And Capital Lease Obligation - - - -
Current Debt - - - -
Other Current Borrowings - - - -
Liabilities
Total Liabilities Net Minority Interest $121,220,555 $2,413,982 $1,815,046 $1,144,973
Total Non Current Liabilities Net Minority Interest $117,934,191 $0 $0 $0
Non Current Deferred Liabilities $117,934,191 $0 - -
Non Current Deferred Taxes Liabilities $117,934,191 $0 - -
Current Liabilities $3,286,364 $2,413,982 $1,815,046 $1,144,973
Payables And Accrued Expenses $3,286,364 $2,413,982 $1,815,046 $1,144,973
Payables $1,090,274 $1,089,666 $908,577 $954,505
Accounts Payable $1,090,274 $1,089,666 $908,577 $954,505
Interest Payable - - - $0
Other Current Liabilities - - - -
Equity
Common Stock Equity $397,925,880 $1,307,642 $9,131,347 $5,543,655
Total Equity Gross Minority Interest $397,925,880 $1,307,642 $9,131,347 $5,543,655
Stockholders Equity $397,925,880 $1,307,642 $9,131,347 $5,543,655
Retained Earnings $-72,817,344 $-36,901,094 $-24,703,526 $-15,384,432
Other
Treasury Shares Number $246 $246 $242 $242
Ordinary Shares Number $37,112,220 $1,973,753 $782,645 $30,704
Share Issued $37,112,466 $1,973,999 $782,887 $30,946
Tangible Book Value $-103,834,489 $1,307,642 $9,131,347 $5,543,655
Invested Capital $397,925,880 $1,307,642 $9,131,347 $5,543,655
Working Capital $14,099,702 $1,307,642 $9,131,347 $5,543,655
Total Capitalization $397,925,880 $1,307,642 $9,131,347 $5,543,655
Treasury Stock $69,965 $69,965 $69,965 $69,965
Additional Paid In Capital $470,809,478 $38,278,503 $33,904,749 $20,998,006
Capital Stock $3,711 $198 $89 $46
Common Stock $3,711 $198 $89 $46
Preferred Stock $0 $0 $0 $0
Current Accrued Expenses $2,196,090 $1,324,316 $906,469 $190,468
Dueto Related Parties Current - - - $0
Fetched: 2026-06-14
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-93,700,883 $-10,901,991 $-7,300,106 $-6,557,950
Operating Activities
Operating Cash Flow $-16,128,316 $-10,901,991 $-7,300,106 $-6,557,950
Cash Flow From Continuing Operating Activities $-16,128,316 $-10,901,991 $-7,300,106 $-6,557,950
Operating Gains Losses $22,010,362 - - -
Investing Activities
Capital Expenditure $-77,572,567 - - -
Investing Cash Flow $-77,572,567 $0 $0 $0
Cash Flow From Continuing Investing Activities $-77,572,567 $0 - -
Financing Activities
Issuance Of Capital Stock $115,672,891 $4,187,729 $12,234,929 $13,645,643
Financing Cash Flow $107,174,270 $3,526,000 $11,724,924 $13,064,128
Cash Flow From Continuing Financing Activities $107,174,270 $3,526,000 $11,724,924 $13,064,128
Net Other Financing Charges $-9,981,802 $-661,729 $-519,180 $-521,294
Net Common Stock Issuance $115,672,891 $4,187,729 $12,234,929 $13,575,678
Common Stock Issuance $115,672,891 $4,187,729 $12,234,929 $13,645,643
Repurchase Of Capital Stock - - $0 $-69,965
Other
Repayment Of Debt $-221,869 $0 $0 $-139,645
Interest Paid Supplemental Data $28,345 $13,684 $16,505 $22,241
End Cash Position $17,032,748 $3,559,361 $10,935,352 $6,510,534
Beginning Cash Position $3,559,361 $10,935,352 $6,510,534 $4,356
Changes In Cash $13,473,387 $-7,375,991 $4,424,818 $6,506,178
Proceeds From Stock Option Exercised $1,705,050 $0 $9,175 $24,389
Net Issuance Payments Of Debt $-221,869 $0 $0 $-14,645
Net Long Term Debt Issuance $-221,869 $0 $0 $-14,645
Long Term Debt Payments $-221,869 $0 $0 $-139,645
Net Intangibles Purchase And Sale $-77,572,567 $0 - -
Purchase Of Intangibles $-77,572,567 $0 - -
Change In Working Capital $986,408 $564,714 $837,126 $-569,112
Change In Payables And Accrued Expense $1,294,463 $598,936 $670,073 $-461,688
Change In Accrued Expense $1,071,986 $417,847 $716,001 $-120,518
Change In Payable $222,477 $181,089 $-45,928 $-341,170
Change In Account Payable $222,477 $181,089 $-45,928 $-141,170
Change In Prepaid Assets $-308,055 $-34,222 $167,053 $-107,424
Other Non Cash Items $100,421 $20,550 $350,000 $1,683,648
Stock Based Compensation $2,877,856 $710,313 $831,862 $800,696
Deferred Tax $-6,187,113 $0 - -
Deferred Income Tax $-6,187,113 $0 - -
Gain Loss On Sale Of PPE $22,010,362 $0 - -
Net Income From Continuing Operations $-35,916,250 $-12,197,568 $-9,319,094 $-8,473,182
Issuance Of Debt - - $0 $125,000
Common Stock Payments - - $0 $-69,965
Long Term Debt Issuance - - $0 $125,000
Change In Interest Payable - - $0 $7,237
Fetched: 2026-06-14